Latest news with #T2T
Yahoo
28-04-2025
- Sport
- Yahoo
Second annual Tunnel to Towers 5K Run & Walk in Preston to be held in November
PRESTON — Registration for the 5th annual Tunnel to Towers 5K Run & Walk in Preston opens on May 1. The Tunnel to Towers Foundation (T2T), established in memory of fallen 9/11 firefighter Stephen Siller, has a mission to honor and support first responders and the military, approved plans to hold its second annual Tunnel to Towers 5K Run & Walk in Preston on Nov. 15. Since 9/11, T2T has been helping America's heroes by providing mortgage-free homes to Gold Star and Fallen First Responder families with young children and by building specially-adapted smart homes for catastrophically injured veterans and first responders. The organization also is committed to eradicating veteran homelessness and helping America to 'Never Forget Sept. 11, 2001.' Participants will be able to register online, and non-runners can sign up for the brand new cornhole tournament. Kids will enjoy a 40-yard Donut Dash prior to the 5k, so sign them up, too. Participants can compete to raise the most funds and recruit the most friends to their team for a chance to win a goody basket full of donations from sponsors of the event. The Preston 5K Run & Walk will be held at the Centerpoint Schoolhouse at 3420 County Road 124 in Preston. Participants will enjoy live music by Daniel Houze from Mississippi. There also will be free activities like bounce houses, massages for participants, face painting and more. Every participant will receive a medal and T-shirt (with early registration). The Preston 5K Run & Walk is the latest of more than 80 events in a national series of 5Ks and tower climbs held all around the United States in support of the Tunnel to Towers Foundation. If interested in participating, volunteering, donating or sponsoring, contact Volunteer Race Director Casie Dring at prestonrun@ or call (941) to register.
Sharjah 24
14-03-2025
- Health
- Sharjah 24
Khaled bin Mohamed chairs Emirates Genome Council meeting
Advancing precision medicine and public health During the meeting, the board discussed plans to prioritise precision medicine initiatives aimed at enhancing public health, improving the efficiency of the healthcare system, driving economic growth, and establishing the UAE as a global leader in genomics. Sheikh Khaled reaffirmed the UAE leadership's commitment to advancing health and wellbeing through research and development in longevity, precision medicine, and preventative care. New population screening programmes His Highness Sheikh Khaled endorsed new population screening programmes to accelerate genome-driven personalised healthcare. These programmes include newborn genetic screenings, adult disease screenings, personalised fertility programmes, and cardiovascular genetic screenings. These initiatives aim to identify genetic conditions early and provide personalised treatments for affected individuals. Updates on key genomic research and initiatives Sheikh Khaled was briefed on the completion of the Telomere-to-Telomere (T2T) Emirati Reference Genome study, which aims to enhance precision medicine by filling gaps in genomic data. He was also updated on the progress of the Premarital Genetic Screening Programme, launched in January 2025, which supports couples in making informed family planning decisions by identifying genetic compatibility and providing personalised counseling. Emirati Genome Programme progress The Emirati Genome Programme has made significant progress, with more than 700,000 genetic samples collected from UAE citizens. Additionally, the program has started collecting samples from other nationalities to address global gaps in genomic data and promote international collaboration in precision medicine research. Future of healthcare transformation The Emirati Genome Programme is a critical component of the National Genome Strategy and will play a pivotal role in transforming healthcare services in the UAE. By providing high-quality genetic data, it will help researchers and healthcare providers understand genetic diseases, predict disease susceptibility, and create personalised healthcare plans. Attendees of the meeting The meeting was attended by several key officials, including Mohammad Al Gergawi, UAE Minister of Cabinet Affairs; Sarah bint Yousef Al Amiri, UAE Minister of Education; Omar bin Sultan Al Olama, UAE Minister of State for Artificial Intelligence, Digital Economy, and Remote Work Applications; Mansour Ibrahim Al Mansouri, Chairman of the Department of Health – Abu Dhabi; Saif Saeed Ghobash, Secretary General of the Abu Dhabi Executive Council; and other prominent health leaders.
Al Etihad
14-03-2025
- Health
- Al Etihad
Khaled bin Mohamed bin Zayed chairs Emirates Genome Council meeting
14 Mar 2025 21:11 ABU DHABI (ALETIHAD)His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, has chaired the meeting of the Emirates Genome the meeting, the board discussed plans to prioritise precision medicine initiatives that leverage genomic data to actively enhance public health outcomes for the UAE population, advance the efficiency of the UAE healthcare system, drive economic and industry growth, and further establish the UAE as a global hub for precision medicine through the advancement of R& Highness Sheikh Khaled bin Mohamed bin Zayed reaffirmed that the UAE leadership is committed to further advancing the health and wellbeing of the community and emphasised the importance of research and development in the fields of longevity, precision medicine and preventative care in enhancing public Highness praised efforts to further advance the UAE as a leader at the forefront of global genomic research and application that prioritises health outcomes and enhances quality of life. New population screening programmes During the meeting, His Highness endorsed new population screening programmes that expand the utilisation of genomic data and accelerate genome-driven personalised healthcare in the UAE. The programmes include newborn genetic screenings, enhanced screenings of adult participants in the Emirati Genome Program, provision of personalised fertility programmes, and cardiovascular genetic newborn genetic screening programme will assess genetic conditions with available treatments and early intervention options for infants, assessing 733 genes to test for more than 800 disease screenings, for adults participating in the Emirati Genome Program, aim to further identify actionable and relevant conditions for UAE Nationals, by assessing 94 genes linked to more than 50 genetic personalised fertility programme assesses 186 genes linked to more than 130 genetic conditions, to provide personalised medicine recommendations and treatments for screenings will provide genetic diagnosis and treatment, as well as early prevention, for cardiovascular related conditions through the assessment of more than 800 genes linked to more than 100 genetic conditions. T2T Emirati Reference Genome study His Highness was briefed on the completion of the landmark Telomere-to-Telomere (T2T) Emirati Reference Genome study aimed at advancing precision medicine for communities in the UAE. The study, by the Department of Health – Abu Dhabi, in collaboration with Khalifa University and M42, bridges critical gaps in genomic data and provides a vital resource that enhances the ability to compare with other reference genomes, supporting the advancement of disease research, pharmacogenomics and the development of Emirati-specific targeted therapies. Premarital Genetic Screening Programme updateHis Highness was also briefed on the progress of the Premarital Genetic Screening Programme, which was nationally implemented from January 1, 2025 by the Ministry of Health and Prevention, in collaboration with the Department of Health – Abu Dhabi, Emirates Heath Services, Dubai Health Authority, and strategic partners. To date, it has supported 2,428 couples, finding more than 92 per cent genetically compatible through comprehensive genetic screening of 570 genes linked to more than 840 genetic disorders. Couples who required additional support were provided personalised genetic counselling to assess and diagnose risk factors and offer potential solutions to support family planning programme aims to safeguard community members from hereditary diseases and empower couples to utilise genetic data to make informed decisions in family planning, preserving the health and wellbeing of community members and ensuring a healthier future for generations to come. Emirati Genome Program progressHis Highness was also updated on the progress of the Emirati Genome Program, which has collected more than 700,000 genetic samples from citizens across the nation, marking significant progress towards the overall target of 1 million. In addition, the Emirati Genome Program has completed the collection of 100,000 samples from participants from different nationalities for a new initiative that leverages the UAE's advanced genomic capabilities. The project, in collaboration with M42, helps reduce gaps in genomic data globally by providing insights into genetic mutations affecting over 2.5 billion people across different ethnicities, with the aim to drive further collaboration on precision medicine research and Emirati Genome Program is a key project under the National Genome Strategy and will support the transformation of healthcare services in the UAE by providing high-quality genetic data that enables researchers, physicians and scientists to identify the causes of genetic diseases, understand the type of genetic mutations, anticipate susceptibility to some diseases, and develop effective personalised healthcare plans. The meeting was attended by His Excellency Mohammad Al Gergawi, UAE Minister of Cabinet Affairs; Her Excellency Sarah bint Yousef Al Amiri, UAE Minister of Education; His Excellency Omar bin Sultan Al Olama, UAE Minister of State for Artificial Intelligence, Digital Economy and Remote Work Applications; His Excellency Mansour Ibrahim Al Mansouri, Chairman of the Department of Health – Abu Dhabi; His Excellency Saif Saeed Ghobash, Secretary General of the Abu Dhabi Executive Council; His Excellency Dr Amer Ahmed Al-Sharif, the CEO of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences; and His Excellency Dr Yousif Mohammed Al-Serkal, Director-General of Emirates Health Services.
